Non-Lupus Full House Nephropathy.
Martina UzzoAndreas KronbichlerFederico AlbericiIngeborg BajemaPublished in: Clinical journal of the American Society of Nephrology : CJASN (2024)
Our data support that SLE and non-lupus full house nephropathy are distinct clinical entities, with comparable outcomes. A small subset of patients develops SLE during follow-up. Non-lupus full house nephropathy is addressed by many different names in the literature. The identification of three pathogenetic categories provides further clues for the management of the disease.
Keyphrases
- systemic lupus erythematosus
- disease activity
- end stage renal disease
- rheumatoid arthritis
- chronic kidney disease
- systematic review
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- type diabetes
- machine learning
- patient reported outcomes
- insulin resistance
- electronic health record
- skeletal muscle
- artificial intelligence
- weight loss
- glycemic control